自噬在肝细胞癌中的作用机制研究进展

陈怡璇; 王琳; 夏秀宏; 彭在坤; 丁奕; 史润娇; 雷学芬

doi:10.12259/j.issn.2095-610X.S20230416

自噬在肝细胞癌中的作用机制研究进展

doi: 10.12259/j.issn.2095-610X.S20230416

陈怡璇¹,
王琳²,
夏秀宏³,
彭在坤¹,
丁奕¹,
史润娇^1, ,,
雷学芬^1, ,

1.
昆明医科大学第二附属医院肿瘤科
2.
肝胆胰外科
3.
中医科，云南昆明　650101

基金项目: 国家自然科学基金资助项目（81860423）；云南省教育厅科学研究基金资助项目（2019J1263）

详细信息

作者简介:
陈怡璇（1999～），女，云南昭通人，在读硕士研究生，主要从事肿瘤的临床及基础研究工作

通讯作者:
史润娇，E-mail：shirunjiao@kmmu.edu.cn

雷学芬，E-mail：leixuefen@kmmu.edu.cn

中图分类号: R735.7
计量
- 文章访问数: 3035
- HTML全文浏览量: 2010
- PDF下载量: 31
- 被引次数: 0
出版历程
- 收稿日期: 2023-02-07
- 网络出版日期: 2023-04-12
- 刊出日期: 2023-04-25

Research Progress on the Mechanisms of Autophagy in Hepatocellular Carcinoma

1.
Dept. of Oncology
2.
Dept. of Hepatobiliary Surgery
3.
Dept. of Traditional Chinese Medicine， The 2nd Affiliated Hospital of Kunming Medical University,Kunming Yunnan 650101，China

摘要

摘要: 肝细胞癌是世界上最常见的恶性肿瘤之一，具有恶性程度高、发展速度快等特点，大多数患者一经诊断已无法手术切除。因此，非手术治疗起着越来越重要的作用。尽管近年来随着药物的研发及放射治疗技术的革新，促进了肝细胞癌的疗效取得了较大的进步，但是由于其复发率高、常常出现治疗抵抗等情况使肝细胞癌患者的预后仍然不理想。肝细胞癌的发生、发展是多基因、多事件异常累积的结果，自噬调控过程的失调与肝癌的发生有关。自噬与肝细胞癌的发生发展、转移复发、治疗抵抗有着密切的关系。对自噬在肝细胞癌中的作用机制进行综述，为未来自噬的抗肿瘤研究提供参考。
- 自噬 /
- 肝细胞癌 /
- 研究进展
Abstract: Hepatocellular carcinoma（HCC）, characterized by high malignancy and rapid development, is one of the most common malignant tumors in the world. In most cases the tumor is inoperable when diagnois is made. Therefore, non-surgical treatment plays an increasingly important role. Although the curative effect of hepatocellular carcinoma has made great progress in recent years with the development of drugs and the innovation of radiotherapy technology, the prognosis of patients with hepatocellular carcinoma is still not ideal due to its high recurrence rate and frequent resistance to treatment. The development of hepatocellular carcinoma is the result of abnormal accumulation of multiple genes and cellular events. The autophagy dysregulation can cause the occurrence of hepatocellular carcinoma. Autophagy is closely related to the occurrence and development, metastasis and recurrence, and resistance to treatment of hepatocellular carcinoma. This paper aims to review the mechanisms of autophagy in hepatocellular carcinoma and provide reference for future anti-tumor studies on autophagy.
- Autophagy /
- Hepatocellular Carcinoma /
- Research progress

HTML全文

参考文献(48)

[1]	Siegel R L,Miller K D,Fuchs H E,et al. Cancer statistics,2021[J]. CA Cancer J Clin,2021,1(1):7-33.
[2]	Huang F,Wang B R,Wang Y G. Role of autophagy in tumorigenesis,metastasis,targeted therapy and drug resistance of hepatocellular carcinoma[J]. World J Gastroenterol,2018,24(41):4643-4651. doi: 10.3748/wjg.v24.i41.4643
[3]	Yorimitsu T, Klionsky D J. Autophagy: Molecular machinery for self-eating[J]. Cell Death Differ, 2005, 12 Suppl 2（Suppl 2）: 1542-1552.
[4]	CLARK S L Jr. Cellular differentiation in the kidneys of newborn mice studies with the electron microscope[J]. J Biophys Biochem Cytol,1957,3(3):349-362. doi: 10.1083/jcb.3.3.349
[5]	Helgason G V,Holyoake T L,Ryan K M. Role of autophagy in cancer prevention,development and therapy[J]. Essays Biochem,2013,55:133-151. doi: 10.1042/bse0550133
[6]	Tsukada M,Ohsumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae[J]. FEBS Lett,1993,333(1-2):169-174. doi: 10.1016/0014-5793(93)80398-E
[7]	White E. The role for autophagy in cancer[J]. J Clin Invest,2015,125(1):42-46. doi: 10.1172/JCI73941
[8]	Devis-Jauregui L,Eritja N,Davis M L,et al. Autophagy in the physiological endometrium and cancer[J]. Autophagy,2021,17(5):1077-1095. doi: 10.1080/15548627.2020.1752548
[9]	Ohsumi Y. Historical landmarks of autophagy research[J]. Cell Res,2014,24(1):9-23. doi: 10.1038/cr.2013.169
[10]	Sun Y,Yao X,Levine B,et al. Beclin-1-dependent autophagy protects the heart during sepsis[J]. Circulation,2018,138(20):2247-2262. doi: 10.1161/CIRCULATIONAHA.117.032821
[11]	Liang X H,Jackson S,Seaman M,et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1[J]. Nature,1999,402(6762):672-676. doi: 10.1038/45257
[12]	Qu X,Yu J,Bhagat G,et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene[J]. J Clin Invest,2003,112(12):1809-1820. doi: 10.1172/JCI20039
[13]	Yue Z,Jin S,Yang C,et al. Beclin 1,an autophagy gene essential for early embryonic development,is a haploinsufficient tumor suppressor[J]. Proc Natl Acad Sci U S A,2003,100(25):15077-15082. doi: 10.1073/pnas.2436255100
[14]	Rosenfeldt M T,Nixon C,Liu E,et al. Analysis of macroautophagy by immunohistochemistry[J]. Autophagy,2012,8(6):963-969. doi: 10.4161/auto.20186
[15]	Inami Y,Waguri S,Sakamoto A,et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells[J]. J Cell Biol,2011,193(2):275-284. doi: 10.1083/jcb.201102031
[16]	Bai Z,Peng Y,Ye X,et al. 自噬与癌症的治疗: 自噬的四种功能形式及其在癌症治疗中的应用(英文)[J]. Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2022,23(2):89-102.
[17]	Kanzawa T,Kondo Y,Ito H,et al. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide[J]. Cancer Res,2003,63(9):2103-2108.
[18]	Butler D,Brown Q B,Chin D J,et al. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation[J]. Rejuvenation Res,2005,8(4):227-237. doi: 10.1089/rej.2005.8.227
[19]	Yun C W,Lee S H. The roles of autophagy in cancer[J]. Int J Mol Sci,2018,19(11):3466.
[20]	成娟. 自噬在白血病K562/ADM细胞多药耐药性及三氧化二砷抗白血病效应中的作用[D]. 兰州: 兰州大学博士学位论文, 2013.
[21]	Xu R,Ji Z,Xu C,et al. The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: A systematic review and meta-analysis[J]. Medicine (Baltimore),2018,97(46):e12912.
[22]	李双辉,陈艳华,吕莹. 自噬与肿瘤化疗耐药的研究进展[J]. 肿瘤药学,2022,12(3):331-336. doi: 10.3969/j.issn.2095-1264.2022.03.07
[23]	黄丽娟,王剑松,王海峰. 自噬机制在肿瘤化疗中的研究进展[J]. 医学与哲学(B),2017,38(2):70-72,90.
[24]	许羚雁, 黄子京, 刘玉波, 等. 巨噬细胞迁移抑制因子介导缺氧诱导的保护性自噬对肝癌细胞化疗敏感性影响的机制研究[J]. 中国免疫学杂志, 2022, 38（23）:2886-2890.
[25]	Kim D G,Jung K H,Lee D G,et al. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin[J]. Oncotarget,2014,5(12):4438-4451. doi: 10.18632/oncotarget.2034
[26]	杜海磊,杨卫平,陈聆,等. 自噬的特异性抑制对肝癌细胞凋亡的调控及其相关机制[J]. 外科理论与实践,2010,15(6):636-640.
[27]	李旸,刘卓刚. 细胞自噬在肿瘤化疗耐药中的作用[J]. 现代肿瘤医学,2016,24(20):3307-3312.
[28]	Pasquier B. Autophagy inhibitors[J]. Cell Mol Life Sci,2016,73(5):985-1001. doi: 10.1007/s00018-015-2104-y
[29]	张笑天,陈欣菊. 原发性肝癌TACE术后复发进展的探究[J]. 中国医学创新,2019,16(31):159-164. doi: 10.3969/j.issn.1674-4985.2019.31.040
[30]	Yang J,Pi C,Wang G. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells[J]. Biomed Pharmacother,2018,103:699-707. doi: 10.1016/j.biopha.2018.04.072
[31]	Zhang D,Wang W,Sun X,et al. AMPK regulates autophagy by phosphorylating BECN1 at threonine 388[J]. Autophagy,2016,12(9):1447-1459. doi: 10.1080/15548627.2016.1185576
[32]	Li Y,Chen Y. AMPK and autophagy[J]. Adv Exp Med Biol,2019,1206:85-108.
[33]	Xu Y,An Y,Wang Y,et al. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells[J]. Oncol Rep,2013,29(5):2019-2024. doi: 10.3892/or.2013.2338
[34]	宋玉姣. 自噬在CD133+肝癌干细胞耐受缺氧缺营养肿瘤微环境中的作用及机制研究[D]. 上海: 第二军医大学硕士学位论文, 2013.
[35]	Wang X,Deng Q,Feng K,et al. Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via autophagy and the CD133 feedback loop[J]. Oncol Rep,2018,40(1):241-251.
[36]	Zhou X,Chen D,Yan Y,et al. The nociceptin receptor promotes autophagy through NF-kB signaling and is transcriptionally regulated by E2F1 in HCC[J]. Cell Death Discov,2022,8(1):165. doi: 10.1038/s41420-022-00978-7
[37]	Li Q,Ni Y,Zhang L,et al. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation[J]. Signal Transduct Target Ther,2021,6(1):76. doi: 10.1038/s41392-020-00453-8
[38]	Han Z,Jing Y,Xia Y,et al. Mesenchymal stem cells contribute to the chemoresistance of hepatocellular carcinoma cells in inflammatory environment by inducing autophagy[J]. Cell Biosci,2014,4:22. doi: 10.1186/2045-3701-4-22
[39]	Keating G M. Sorafenib: A review in hepatocellular carcinoma[J]. Target Oncol,2017,12(2):243-253. doi: 10.1007/s11523-017-0484-7
[40]	Lendvai G,Szekerczés T,Illyés I,et al. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor[J]. PLoS One,2021,16(6):e0253065. doi: 10.1371/journal.pone.0253065
[41]	Tai W T,Shiau C W,Chen H L,et al. Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells[J]. Cell Death Dis,2013,4(2):e485. doi: 10.1038/cddis.2013.18
[42]	薛斌跃. 放射治疗是癌症治疗的重要手段[J]. 家庭生活指南,2020,(4):163.
[43]	Shi TT,Yu XX,Yan LJ,et al. Research progress of hydroxychloroquine and autophagy inhibitors on cancer[J]. Cancer Chemother Pharmacol,2017,79(2):287-294. doi: 10.1007/s00280-016-3197-1
[44]	Zhan Y,Zhang Z,Liu Y,et al. NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR/CYP signal axis in hepatocellular carcinoma[J]. BMC Med,2022,20(1):365. doi: 10.1186/s12916-022-02554-3
[45]	Kuwahara Y,Oikawa T,Ochiai Y,et al. Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy[J]. Cell Death Dis,2011,2(6):e177. doi: 10.1038/cddis.2011.56
[46]	Kim K W,Mutter R W,Cao C,et al. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling[J]. J Biol Chem,2006,281(48):36883-36890. doi: 10.1074/jbc.M607094200
[47]	Gao L,Zheng H,Cai Q,et al. Autophagy and tumour radiotherapy[J]. Adv Exp Med Biol,2020,1207:375-387.
[48]	Xu Y,Ji Y,Li X,et al. URI1 suppresses irradiation-induced reactive oxygen species (ROS) by activating autophagy in hepatocellular carcinoma cells[J]. Int J Biol Sci,2021,17(12):3091-3103. doi: 10.7150/ijbs.55689

相关文章(20)

[1]	邓苙, 丛林海, 方红丽, 高慧芳, 殷家志. 中国人群新生儿常见耳聋基因筛查研究进展, 昆明医科大学学报.
[2]	张怡雯, 王锡铭, 李子龙, 张新章, 陈昌贤, 刘为军, 张振勇. 人工智能在肛肠疾病诊治中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240201
[3]	张雪莎, 周杰, 李彩琳, 吴定宇, 彭芳. 美洲大蠊提取物对肝癌皮下移植瘤裸鼠自噬和侵袭转移的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231018
[4]	梁晨晨, 高建鹏. MSCs通过调控AMPK/mTOR促进自噬改善NASH肝损伤, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230728
[5]	杨诗媛, 张昊, 胡图强. 扁塑藤素通过调节自噬对口腔鳞状细胞癌细胞CAL-27增殖的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231024
[6]	张紫微, 郑甲林, 许晓宇, 王红. 二甲双胍通过AMPK/PPAR-γ通路诱导自噬抑制高糖对血管平滑肌细胞的增殖作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231026
[7]	张明, 于成龙, 曹锦鹏. ZNF384调控GCLM对肝细胞癌转移的机制研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231108
[8]	陈诗, 付什, 谭智勇, 王剑松, 王海峰. 自噬在膀胱癌发展和治疗中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230503
[9]	张桂煊, 石鑫, 李伟, 叶淑华. 影像组学在肾上腺肿瘤中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220324
[10]	付海艳, 闫俊芳, 李红娟, 王霖, 张洁, 周宇君, 徐斌, 罗煜. 时间间隔对肝动脉化疗栓塞术序贯微波消融治疗肝细胞癌的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221127
[11]	王子涵, 叶改映, 赵涛, 张俊, 胡瑜. mTOR在SD大鼠TMJOA髁突软骨中表达变化的实验研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221033
[12]	张天红, 杨红菊. 外泌体miRNA在肝细胞癌中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220221
[13]	曹凡, 刘阳文, 魏雷, 谢楠, 杨裔坚, 钱程, 李春满, 付必莽, 胥江品, 阎容稷, 曾汪. 乙型肝炎病毒与肝细胞癌微血管侵犯的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210331
[14]	刘永骏, 王颖, 杨眉, 殷娥高, 李婷, 董昭兴. 氢气水调控自噬对百草枯中毒大鼠肺纤维化的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210918
[15]	沈宝玉, 杨根梦, 李媛媛, 刘柳, 黄俭, 曾晓锋, 李利华. 可卡因诱导神经细胞自噬的研究进展, 昆明医科大学学报.
[16]	李晶, 雷雯, 邓树豪, 樊都, 普玲, 杨冬梅, 赵晓远, 李洋, 董昭兴. 不同浓度百草枯对人支气管上皮细胞自噬的影响, 昆明医科大学学报.
[17]	谭骅, 仁虹, 赵玲, 游顶云, 杨亚琛. 行TACE治疗后原发性肝细胞癌患者预后的影响因素, 昆明医科大学学报.
[18]	雷喜锋, 侯峰强, 刘韬, 张伟. FOXP2抑制人肝细胞癌增殖及其机制, 昆明医科大学学报.
[19]	雷喜锋, 侯峰强, 杨少华, 张伟. miR-373在人肝细胞癌中的表达及其作用, 昆明医科大学学报.
[20]	. 丝氨酸蛋白酶抑制剂对新生血管抑制作用的研究进展, 昆明医科大学学报.